Hemab Therapeutics To Present Two Presentations At American Society Of Hematology Annual Meeting
Benzinga Newsdesk 4 hours ago
News
Hemab Therapeutics (Nasdaq:COAG), a clinical-stage biotechnology company developing therapies that reimagine the treatment of blood coagulation disorders to sustain life and human resilience, today announced two
Hemab Therapeutics (Nasdaq:COAG), a clinical-stage biotechnology company developing therapies that reimagine the treatment of blood coagulation disorders to sustain life and human resilience, today announced two presentations showcasing progress from multiple pipeline programs at the upcoming 68th American Society of Hematology (ASH) Annual Meeting and Exposition in New Orleans, Louisiana, and virtually from December 12–15, 2026.